Stem cell lines on hold

Three human embryonic stem cell lines once eligible for federal funding are "on hold" until further notice because they were derived from embryos that were too early. Human embryonic stem cellsImage: Wikimedia commons, Nissim Benvenisty"These lines were derived from early embryos -- those consisting of 6, 8, or 16 cells -- and thus formally did not fit the official definition of ES cells by the NIH," linkurl:George Daley,;http://daley.med.harvard.edu/ who derived these particular lines and subm

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Three human embryonic stem cell lines once eligible for federal funding are "on hold" until further notice because they were derived from embryos that were too early.
Human embryonic stem cells
Image: Wikimedia commons,
Nissim Benvenisty
"These lines were derived from early embryos -- those consisting of 6, 8, or 16 cells -- and thus formally did not fit the official definition of ES cells by the NIH," linkurl:George Daley,;http://daley.med.harvard.edu/ who derived these particular lines and submitted them for approval to the NIH last year, told The Scientist in an email. The current definition is limited to "cells that are derived from the inner cell mass of blastocyst-stage human embryos" -- a stage that the three lines on hold "failed to reach," said an NIH spokesperson. Last February, the NIH published a linkurl:notice in the Federal Register;http://edocket.access.gpo.gov/2010/pdf/2010-3527.pdf that proposed a change in the formal definition of human embryonic stem cell to include such early embryos. The issue of whether cell lines derived from early embryos could be approved for federal funding was initially raised when stem cell company Advanced Cell Technology submitted five stem cell lines similarly derived from early embryos to the NIH for inclusion on the linkurl:stem cell registry,;http://grants.nih.gov/stem_cells/registry/current.htm linkurl:according to ScienceInsider.;http://news.sciencemag.org/scienceinsider/2010/02/nih-expands-definition-of-human-.html The NIH declined to say how it was realized that the three already approved lines also fell outside of the official definition set forth by the NIH. The proposed change has received public comment that is currently being considered by the NIH, during which time the lines -- three of the first to be approved for federal funding under the new NIH guidelines -- "should not be used in NIH-funded research," according to linkurl:the notice;http://grants.nih.gov/stem_cells/registry/current.htm#hold on the stem cell registry. When asked about the impact of such a hold on current research using these lines, Daley said that the lines "are generic and people are using others." NIH declined to comment on how the lines were approved in the first place when they did not meet the formal definition in the new guidelines.
**__Related stories:__***linkurl:News in a nutshell;http://www.the-scientist.com/blog/display/57155/
[22nd February 2010]*linkurl:Popular hESC line approved;http://www.the-scientist.com/blog/display/57382/
[27th April 2010]*linkurl:27 more hESC lines approved;http://www.the-scientist.com/blog/display/56219/
[15th December 2009]*linkurl:NIH OKs 13 stem cell lines;http://www.the-scientist.com/blog/display/56196/
[2nd December 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio